horizont
News
21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea
“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
09.10.2015
SOLTA MEDICAL RAIDS DISTRIBUTOR OF COUNTERFEIT THERMAGE® MACHINES
Solta Medical, Inc. (“Solta“), a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc., announced today a brand enforcement action taken against a distributor of counterfeit Thermage® machines. Solta is […]